Brightsurf Science News and Current Science News Events
 
Tell a Friend About:
Adding epratuzumab to standard therapy
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma.

Your Name:
Your E-mail:

Recipient Name:
Recipient E-mail:

Add Your Message:

 
Send confirmation

Verification Code:

  - Please enter the 6 character Verification Code.


Return To Article
© 2008 BrightSurf.com